Full name
"DARRI" APTEKI MAX SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.90.Z - Non-specialized wholesale trade
49.41.Z - Road freight transport
73.11.Z - Advertising agency activities
73.12.B - Advertising through mass media
73.12.C - Advertising through mass media
73.12.D - Advertising through mass media
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 50,7 | |||
Gross profit (loss) | 3,7 | 1,2 | 0,6 | -51 |
EBITDA | 3,3 | 0,5 | 0,1 | -74,1 |
Short time liabilities | 6,2 | 7,7 | 8,9 | 16,4 |
Other operating costs | 186,4 | |||
Equity capital | 3,7 | 1,2 | 0,6 | -50,8 |
Operating profit (EBIT) | 3,3 | 0,4 | 0 | -92,3 |
Assets | 10,1 | 9 | 9,5 | 6,2 |
Net profit (loss) | 3,7 | 1,2 | 0,6 | -51 |
Cash | 1,4 | 0,9 | 0,9 | 4,3 |
Net income from sale | 19,5 | 18,5 | 18,7 | 1,3 |
Liabilities and provisions for liabilities | 6,3 | 7,8 | 8,9 | 15 |
Working assets | 4,7 | 3,5 | 3,7 | 7,6 |
Other income costs | 41,2 | |||
Depreciation | 0 | 0,1 | 0,1 | 11,5 |
% | % | % | p.p. | |
Profitability of capital | 99,9 | 99,6 | 99,1 | -0,5 |
Equity capital to total assets | 37,1 | 13,3 | 6,1 | -7,2 |
Gross profit margin | 19,1 | 6,4 | 3,1 | -3,3 |
EBITDA Margin | 17,1 | 2,9 | 0,7 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 117 | 151 | 174 | 23 |
Current financial liquidity indicator | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane